Home > Publications Database > Dataset: Correction of dysregulated lipid metabolism normalizes gene expression in oligodendrocytes and prolongs lifespan in female poly-GA C9orf72 mouse model > print

001     277510
005     20250320091335.0
037 _ _ |a DZNE-2025-00421
100 1 _ |a Rezaei, Ali
|0 P:(DE-2719)9000720
|b 0
|u dzne
245 _ _ |a Dataset: Correction of dysregulated lipid metabolism normalizes gene expression in oligodendrocytes and prolongs lifespan in female poly-GA C9orf72 mouse model
260 _ _ |c 2025
|b Gene Expression Omnibus
336 7 _ |a MISC
|2 BibTeX
336 7 _ |a Dataset
|b dataset
|m dataset
|0 PUB:(DE-HGF)32
|s 1742379288_10621
|2 PUB:(DE-HGF)
336 7 _ |a Chart or Table
|0 26
|2 EndNote
336 7 _ |a Dataset
|2 DataCite
336 7 _ |a DATA_SET
|2 ORCID
336 7 _ |a ResearchData
|2 DINI
520 _ _ |a Summary: These sequences support the following paper abstract: "Clinical and genetic research links altered cholesterol metabolism with ALS development and progression, yet pinpointing specific pathomechanisms remain challenging. We investigated how cholesterol dysmetabolism interacts with protein aggregation, demyelination, and neuronal loss in ALS. Bulk RNAseq transcriptomics showed decreased cholesterol biosynthesis and increased cholesterol export in ALS mouse models (GA-Nes, GA-CFP, rNLS8) and patient samples (spinal cord), suggesting an adaptive response to cholesterol overload. Consequently, we assessed the efficacy of the cholesterol-binding drug 2-hydroxypropyl-β-cyclodextrin (CD) in a fast-progressing C9orf72 ALS mouse model with extensive poly-GA expression and myelination deficits. CD treatment normalized cholesteryl ester levels, lowered neurofilament light chain levels, and prolonged lifespan in female but not male GA-Nes mice, without impacting poly-GA aggregates. Single nucleus transcriptomics indicated that CD primarily affected oligodendrocytes, significantly restored myelin gene expression, increased density of myelinated axons, inhibited the disease-associated oligodendrocyte response, and downregulated the lipid-associated genes Plin4 and ApoD. These results suggest that reducing excess free cholesterol in the CNS could be a viable ALS treatment strategy.” Overall design: GA-Nes mice (LaClair et al, Acta Neuropathologica 2020) and littermate controls were treated with the cholesterol sequestering drug 2-hydroxypropyl-β-cyclodextrin (CD) or vehicle control from P21 (daily subcutaneous treatment) and harvested on P40. We aim to investigate the mechanisms of lifespan extension and neurofilament reduction with CD treatment in female mice. Includes 15 samples.
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 0
700 1 _ |a Edbauer, Dieter
|0 P:(DE-2719)2231621
|b 1
|u dzne
700 1 _ |a Günes, Zeynep Irem
|0 P:(DE-2719)2812248
|b 2
700 1 _ |a Liebscher, Sabine
|0 P:(DE-2719)9000187
|b 3
700 1 _ |a Bauernschmitt, F.
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Beltran, E.
|0 P:(DE-HGF)0
|b 5
856 4 _ |u https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE262778
909 C O |o oai:pub.dzne.de:277510
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)9000720
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2231621
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 0
914 1 _ |y 2025
920 1 _ |0 I:(DE-2719)1110004
|k AG Edbauer
|l Cell Biology of Neurodegeneration
|x 0
980 _ _ |a dataset
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1110004
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21